Shares of over-the-counter drugmaker Perrigo sank early Friday morning on a report that its stock owners will reject a hostile, $26-billion takeover bid from Mylan.
Search Results - stltoday.com, St. Louis Post-Dispatch: Business
Fri, 11/13/2015 - 5:36am
Shares of over-the-counter drugmaker Perrigo sank early Friday morning on a report that its stock owners will reject a hostile, $26-billion takeover bid from Mylan.